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A-to-I RNA editing can lead to recoding of pre-mRNAs with profound functional consequences for
the ensuing proteins. Here we show that complement component 1, q subcomponent-like 1
(C1QL1) undergoes RNA editing in vivo causing non-synonymous amino acid substitutions in
human, mouse as well as zebraﬁsh. The major editing site had previously been annotated as a
single-nucleotide polymorphism in human, but our analysis reveals that post-transcriptional mod-
iﬁcation is the cause for the sequence variation. Remarkably, although editing of C1QL1 is conserved
across vertebrate species, the predicted RNA secondary structure mediating editing involves differ-
ent regions in zebraﬁsh versus mammals.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The posttranscriptional processing of pre-mRNAs by A-to-I
modiﬁcation has been recognized as an important mechanism for
generating RNA and protein diversity, as edited and non-edited
gene products are usually produced side-by-side within the same
cell (for review see [1–3]). If A-to-I RNA editing occurs within cod-
ing sequences, single amino acid substitutions can be the conse-
quence since inosine is interpreted as guanosine by the
translational machinery. Several mammalian genes have been
described where the substitution of a single amino acid due to
RNA editing leads to a signiﬁcant alteration in protein function
(reviewed in [1]). The deﬁciency or misregulation of A-to-I editing
has been implicated in the etiology of several human disease phe-
notypes (for review see [4]).
Especially, neurotransmitter receptors and other brain-speciﬁc
transcripts are among the previously characterized recoding tar-
gets for editing. Adenosine deaminases acting on RNA (ADARs)
are responsible for the site-selective modiﬁcation of adenosine res-
idues to inosine. Their target speciﬁcities and enzymatic regulation
are not well understood. ADARs harbor double-stranded (ds) RNAchemical Societies. Published by E
on RNA; C1QL1, complement
cleotide polymorphism; ECS,binding domains with high afﬁnity for dsRNA structures, but
known physiological targets for editing lack recognizable primary
sequence motifs or recurring RNA folds to allow straight-forward
prediction of editing sites.
Since editing alters coding information post-transcriptionally,
the genomic sequences of an affected gene are indistinguishable
from a gene that does not undergo editing. It is therefore important
to discriminate DNA-based gene variations (genomic SNPs) from
variations in gene products (RNA or protein) that originate from
recoding events on the level of the RNA transcripts. Single-nucleo-
tide polymorphisms (SNPs) are important molecular markers that
link sequence variations to phenotypic changes. They constitute
the most frequent type of genetic variation in the human genome
[5]. Among the millions of validated genomic SNPs, some polymor-
phisms have been deduced from analyzing only expressed
sequences [6,7]. Therefore, absent of genomic validation, it is pos-
sible that such variations may result from RNA editing events [8].
Focusing on recoding events, we recently performed a screen for
A-to-I RNA editing candidates and identiﬁed two genes, the splic-
ing factor SRp25 and the insulin-like growth factor binding protein
IGFBP7, that are subject to RNA editing at speciﬁc sites within their
coding region and had previously been falsely annotated as SNPs
[9].
Here we show that complement component 1, q subcompo-
nent-like 1 (C1QL1) undergoes A-to-I RNA editing within its open
reading frame leading to non-synonymous codon changes in
human, mouse and zebraﬁsh transcripts. One of the experimentallylsevier B.V. All rights reserved.
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Fig. 2. Editing of human and mouse complement component 1, q subcomponent-
like 1 (C1QL1). (A) A schematic representation of the C1QL1 protein is shown with
the three main functional domains indicated. The amino acid sequence surrounding
the editing sites is shown, and recoding events are indicated both at the amino acid
and at the RNA sequence level. (B) Representative sequence tracks from subcloning
of mouse cerebellum C1QL1. The genomic sequence is at the top. The positions of
the three editing sites are boxed. (C) Representative sequence tracks from
subcloning of human C1QL1. The genomic sequence is at the top. The two editing
sites are boxed. For in vivo editing levels based on all clones analyzed, please refer
to Table S2.
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man emerged as a high scoring candidate editing site in our data-
base screen [9]. The predicted T63A and Q66R amino acid
substitutions may impact protein oligomerization as they are situ-
ated immediately prior to a collagen-like trimerization domain.
Intriguingly, zebra ﬁsh C1QL1 also undergoes RNA editing at the
Q66R site, but uses a different RNA secondary structure that medi-
ates editing.
2. Materials and methods
2.1. Databases and data analysis
Annotations for human single-nucleotide polymorphisms
(SNPs) from the dbSNP database [5] build 125 were downloaded
using the UCSC genome table browser [10]. For subsequent analy-
sis of candidate genes the UCSC human genome browser (assembly
May 2004) was used. RNA secondary structures were predicted
using the M-fold algorithm [11] and multiple sequence alignments
were done with clustal W 1.8.
The bioinformatics screening procedure for the prediction and
scoring of candidate editing sites within the human transcriptome
is described in detail in [9] and summarized in our Supplementary
data.
2.2. RNA editing analysis
For experimental validation, gene-speciﬁc fragments of cDNA as
well as genomic regions were ampliﬁed by PCR and subjected to
dideoxy sequencing as described previously [12]. Human brain to-
tal RNA and gDNA isolated from the same specimen (Biochain, CA)
were used and processed using a standard protocol for reverse
transcription. Ampliﬁcation of C1QL1 cDNA was performed using
an optimized PCR protocol with Phire Hot Start DNA Polymerase
(NEB). For detailed PCR protocols and a list of DNA oligonucleotides
used see Supplementary data. PCR products were gel-puriﬁed with
QIAEX II Gel Extraction Kit (QIAGEN) and subjected to dideoxy
sequencing (Geneway Research).
For further analysis PCR products were subcloned into pBlue-
script II (Stratagene) vector and individual DNA templates were
puriﬁed and sequenced.
For analysis of mouse C1QL1 total RNA and genomic DNA from
cortex and cerebellum of adult mice were prepared using standard
procedures and analyzed following a similar RT-PCR strategy as de-Human
        A   --  A    GCGC       CG     
5’- GUGCG CCC  CU CCCC    GGGGCCC  GCGCC
   ||||| |||  || ||||    |||||||  |||||
3’- CACGC GGG GA GGGG    CCCCGGG  CGUGG
         C   CC  A    -AC-      -A     
  5’-
Mouse
               U                        
         A   --  A    GCGC       CG     
5’- GUGCG CCC  CU UCCC    GGGGCCC  GCGCC
   ||||| |||  || ||||    |||||||  |||||
3’- CACGC GGG  GA GGGG    CCCCGGG  CGUGG
         C   CC  A   -AC-      -A     
                                       
exon 1
Fig. 1. Secondary structure predictions of human, mouse and rat complement componen
pre-mRNA sequences starting from their known 50-ends were analyzed by M-fold [11] a
shown. Within the mouse sequence, bases that differ from human are shaded and thosescribed for human C1QL1. Danio rerio gDNA and total RNA were
isolated from adult and hatchlings (four day post-fertilization)
using the same procedures. See Supplementary data for detailed
protocols, statistical analysis and primer sequences.    CGC   CCGA   C    A    ---   AG
GGCG   GGA    CGG GGCG CGCC   CUG  C||||   |||    ||| |||| ||||   |||   G
UCGC   CCU    GCC CCGC GCGG   GAC  A
   -A-   UCC-   C    -    CGA   G
     -3’
                            C
    CGC  UCCGA   C    -A-    G  AG
GGCG   GG     CGG GGCG   CGCU UG  C  ||||   ||     ||| ||||   |||| || G
UCGC   CC     GCC CCGC   GCGA AC  A
   -A-  UCCC-   U    GUG    G  G
                 C      
exon 2
t 1, q subcomponent-like 1 (C1QL1). Two thousand ﬁve hundred nucleotides of the
nd the structures surrounding the putative editing sites (bold and underlined) are
that are different in rat are shown above the mouse sequence (shaded and boxed).
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3.1. A-to-I RNA editing in mammalian C1QL1
We recently completed a bioinformatics based exploration of
human genome and transcriptome sequence databases predicting
candidate sites for A-to-I editing within human mRNAs [9]. Pre-
dicted candidates are experimentally validated through parallel
analysis of cDNA and genomic DNA isolated from the same individ-
ual to rule out polymorphisms. The experimental strategy employs
standard reverse transcription and PCR to amplify gene-speciﬁc re-
gions that span the predicted editing site followed by sequence
analysis to determine the ratio of edited-to-unedited templates.
Within the highest scoring group of predicted target sites we
showed that three out of four positions are bona ﬁde RNA editing
recoding sites affecting two genes, splicing factor SRp25 and insu-
lin-like growth factor binding protein IGFBP7 [9]. None of the low-
er scoring candidates that we evaluated experimentally (total of 64
sites) showed detectable RNA editing in human brain tissue.
Table S1 shows the top scoring sites for RNA editing within a
subset of 554 human sequences that had previously been anno-
tated as SNPs based solely on expressed sequence data. Human
C1QL1 is a high scoring candidate (Table S1). However, standard
PCR did not allow productive ampliﬁcation of the human C1QL1
cDNA fragment, probably due to its high G/C content. We used to-
tal mouse RNA to optimize reaction conditions for a RT-PCR proto-
col that will allow RNA editing analysis. Not only is the mouse
C1QL1 cDNA highly conserved to the human sequence, also the
predicted RNA secondary structures of mouse, rat and human exon
1 sequences are the same (Fig. 1). Therefore, we hypothesized that
RNA editing at the candidate position in human would also be con-
served in the mouse C1QL1 orthologue. We isolated total RNA from
both cortex and cerebellum of two mouse brains.
Use of a special DNA polymerase, a special buffer and optimized
ampliﬁcation protocols allowed us to obtain a speciﬁc amplicon forA     ------------------------(((((-(((((-((((-------((((((hu  GATGCTGGGCACCTGCCGCATGGTGTGCGACCCCTACCCCGCGC---GGGGCC
mo  GATGCTGGGCACCTGCCGCATGGTGTGCGACCCCTATCCCGCGC---GGGGCC
ra  GATGCTGGGCACCTGCCGCATGGTGTGCGACCCTTATCCCGCGC---GGGGCC
cow GATGCTGGGCACCTGCCGCATGGTGTGTGACCCCTACCCCGCGC---GGGGCC
dog GATGCTGGGCACCTGCCGCATGGTATGCGACCCCTACCCCGCGC---GGGGCC
fug GATGTTGGGCACCTGTCGTATGGTGTGCGACCCCTACCTGAACA-19nt-CAC
zeb GATGCTGGGCACCTGTCGAATGGTGTGCGATCCATACCAGAACA-19nt--CG
    ****************** *********** ** ** *             
     ))))-)))----))-)))))---))))-)))))))--))))-))--)))-))
hu  GCGCCCCCGCCTTCCACGCTG---GTGCAGGGCCCCCAGGGGAAGCCGGGCCG
mo  GCGCCTCCGCCCTCCACGCTG---GTGCAGGGCCCCCAGGGGAAGCCGGGCCG
ra  GCGCCCCCGCCCTCCACGCTG---GTGCAGGGCCCCCAGGGGAAGCCGGGCCG
cow GCGCCCCCGCCCTCCACGCTG---GTGCAGGGCCCCCAGGGGAAGCCGGGACG
dog GCGCCCCCGCCTTCCACGCTG---GTGCAGGGCCCCCAGGGGAAACCGGGCCG
fug GTGCACCCTCCTTCAACTTTA---CTACAGGGTCCACAAGGGAAGCCTGGCAG
zeb ATGCCTCCACCCTCTACGCTC---CTCCAGGGGCCACCGGGGAAGCCGGGCCG
     ** ** ** ** **  *     * ***** ** * ***** ** **  *
                     ((((---(((--((((((-((((((---(((((((-
B Zebrafish
      AC       CA      A      AAG           G
5’-     GCUCCUC  GGGGCC CCGGGG   CCGG----GCC A
        |||||||  |||||| ||||||   ||||    |||  C
3’-     CGAGGGG  CUCCGG GGCCUC   GGCC    CGG C  
     CA      AC     -     -CA    CAAA  A
Fig. 3. Distinct RNA folds mediate editing in mammals versus zebraﬁsh. (A) Clustal W
(C1QL1) sequences and RNA secondary structures that mediate editing. Exon1 sequences
mammalian structure are depicted with purple shading for the sequence surrounding t
region. Nucleotides involved in base-pairing in the zebraﬁsh RNA structure are show
complementary region). Adenosines that were experimentally shown to be subject to edi
species are indicated by a star; base-pairing nucleotides are further highlighted through
zebraﬁsh sequences were analyzed using M-fold [11] and the predicted structure surr
(underlined and gray shading) are shown.C1QL1 cDNA. The analysis of puriﬁed cortex and cerebellum sam-
ples revealed three positions of RNA editing within the same exon
of C1QL1, all causing non-synonymous codon changes. The Q66R
site had been predicted by our computational screen ([9] and Table
S1), while the others alter a threonine (ACG) to an alanine codon
(GCG) and a glutamine (CAG) to arginine (CGG) codon, respec-
tively. Table S2 summarizes the editing levels measured at the
three sites within the two mice. Intriguingly, in both specimens,
editing levels in cerebellum are substantially different from those
in cortex arguing for tissue-speciﬁc regulation of editing. The
Q66R site is edited to 10% or 17% in cerebellum, whereas it is edi-
ted to only 1–3% in cortex. Q69R only showed evidence of editing
in cerebellum (3–7%) and the T63A site is modiﬁed 1–2% in both
cortex and cerebellum (Table S2).
Taken together, we conﬁrmed that all three sites in mouse
C1QL1 undergo RNA editing in vivo leading to non-synonymous
codon changes. We then moved to the analysis of human speci-
mens applying the optimized protocols to several human brain
RNAs. One sample showed high levels of modiﬁcation at T63A
(18% editing) and Q66R (56% editing) (Fig. 2, Table S2).
Since for this human specimen the genomic counterpart was
not available, we analyzed three additional specimens from human
brain together with the corresponding genomic DNA. In two of the
three cases we conﬁrmed the occurrence of RNA editing at the
Q66R position since the genome samples displayed an adenosine
at both sites in C1QL1 (Fig. 2 and Table S2). In these two human
specimens, editing at the T63A site was not detectable. Although
we can therefore formally not rule out that in human the T63A site
represents a previously unknown gSNP, our results from analysis of
mouse C1QL1 and the complete conservation of the predicted RNA
secondary structure surrounding the editing sites argue that, like
in mouse, the T63A position is also an A-to-I editing site in human.
The observed variation in editing levels at both the major and
minor sites in human specimens may be due to regional and/or
temporal regulation of C1QL1 editing, similar as observed for other(--(((((((((----((-----(--((-((((-(((((((------)))---)--
CCGGCGCCGGCGCG-CGGACCGAC--GGCGGCGACGCCCTGAGCGAGCAGAGCGGC
CCGGCGCCGGCGCG-CGGTCCGAC--GGCGGCGACGCTCTGAGCGAGCAGAGCGGT
CCGGCGCCGGCGCG-CGGTCCGAC--GGCGGCGACGCTCTGAGCGAGCAGAGCGGT
CCGGCGCCGGCGCG-CGGCCCGAC--GGCGGCGACGCCCTGAGCGAGCAGAGCGGC
CCGGCGCCGGCGCT-CGGCCCGAC--GGCGGCGACGCCCTGAGCGAGCAGAGTGGC
CAGTTCCA-CCGGTC---TTCAGGCTGAGGCTGAGGCATTGAGTGACCACAGCAAT
CCAGCACCGGCTCTTCTGTACAGGCCGAGGCCGAGGCTCTGGCCGACCACAGCAAC
*   *   * *  * *  *     *  * ** ** **  ** ** **_____
)))
CACCGGCAAGCCCGGCCCTCCGGGGCCTCCCGGGGACCCAGGTCCTCCCGGCCCTG
CACGGGCAAGCCGGGCCCTCCGGGGCCTCCAGGAGACCGGGGCCCTCCAGGTCCTG
CACCGGCAAGCCAGGCCCCCCCGGGCCTCCAGGAGACCGGGGACCTCCAGGTCCTG
CACAGGCAAGCCGGGCCCCCCTGGGCCCCCCGGGGACCCAGGTCCTCCGGGTCCTG
CACAGGCAAGCCGGGCCCCCCGGGGCCTCCCGGGGACCCAGGTCCTCCGGGCCCTG
GCCAGGAAAGCCAGGACCACCCGGACCACCAGGAGAACCAGGCCCACCAGGACCAG
ACCAGGCAAACCCGGACCTCCGGGGCCTCCAGGGGAGCCAGGGCCCCCGGGTCCAA
  * ** ** ** ** ** ** ** ** ** ** ** *  ** ** ** ** **
----)))----))))--))))))))))))--)))))))
(1.81) alignment of vertebrate complement component 1, q subcomponent-like 1
were retrieved from the UCSC Genome Browser [10]. Base-paired nucleotides in the
he recoding editing sites and in yellow shading for the upstream, complementary
n in purple (region around the recoding editing site) and green (downstream
ting are shown in red with yellow shading. Nucleotides identical across all displayed
bracket notation. (B) Zebraﬁsh computer predicted RNA secondary structure. C1QL1
ounding the Q74R editing site (bold and underlined) as well as other minor sites
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scripts [13]. That assumption is supported by the tissue-speciﬁc
pattern of editing in mouse brain tissue described above. We also
analyzed human lung, kidney and spleen RNA samples for editing
in C1QL1 but did not detect evidence of editing above the detection
limit of <5% for direct sequence track analysis.
The family of C1Q-domain proteins includes important signal-
ing molecules with roles in inﬂammation, adaptive immunity
and energy homeostasis [14]. The physiological function of
C1QL1 has not been elucidated, but it is expressed highest within
the brain and was suggested to be especially important for neurons
involved in coordination and regulation of motor control [15]. Fur-
thermore, it may be part of a neuroprotective immune response
[16]. Interestingly, one study revealed upregulation of C1QL1 in re-
sponse to kainic acid induced seizures [17]. Kainate is the speciﬁc
agonist for the ionotropic glutamate receptors GluR-5 and Glu-6,
both of which are also regulated through A-to-I RNA editing.
The RNA editing sites in C1QL1 are located immediately up-
stream and at the beginning of a collagen-like domain. In other
C1Q-domain proteins, such as the hormone adiponectin, this coin-
cides with a region of protease-mediated processing [18]. Future
studies will show if the amino acid substitutions caused by RNA
editing may alter post-translational processing of C1QL1, or if it af-
fects other properties of the protein in vivo.
Our ﬁndings validating mammalian C1QL1 as a bona ﬁde A-to-I
RNA editing target further highlights the effectiveness of our bioin-
formatics search strategy as applied to the subset of humanmRNAs
with non-synonymous A/G discrepancies chosen from the SNP
database. Four of the top ﬁve highest scoring sites (80%) prove to
be in vivo editing targets, whereas none of the tested sites with
lower scores (an additional 60 positions tested) show detectable
editing. This analysis sets the stage for a systematic, genome-wide
screen for A-to-I recoding events in human and other organisms.
3.2. A distinct RNA fold supports zebraﬁsh C1QL1 editing
The C1QL1 exon 1 sequence is strongly conserved between
mammalian species (Figs. 1 and 3) and suggests that in addition
to the human and mouse gene, also the rat, cow and dog C1QL1
RNA is likely subject to editing. However, we noticed that the pre-
dicted secondary structure supporting editing in mammalian
C1QL1 is not conserved within the zebraﬁsh (Danio rerio) ortho-
logue (Fig. 3). The editing site complementary sequence (ECS)
within human exon 1, located 50 to the recoding editing sites, is
not conserved in any of the non-mammal sequences including zeb-
raﬁsh. However, in zebraﬁsh, another RNA fold of similar strength
is formed with sequences downstream of the recoding sites within
exon 1. Indeed, when we analyze RNAs isolated from adult and
four day post-fertilization zebraﬁsh specimens, we readily detect
editing at the Q74R site (equivalent to human Q66R) of about
50% in adult and 33% in hatchlings (Table S2).
The distinct RNA fold predicted for the zebraﬁsh sequence is
supported by the fact that two additional adenosines located on
the opposite site of the predicted duplex also undergo editing(see Fig. 3). In contrast, human C1QL1 does not show any evidence
of editing at the downstream adenosines.
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